Cite
HARVARD Citation
Pedrol, E. et al. (2015). Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study. HIV clinical trials. 16 (1), pp. 43-48. [Online].